The metabolic syndrome among postmenopausal women in Ecuador

Gynecological Endocrinology

Volumn 22, Issue 8, 2006, Pages 447-454

  Hidalgo, Luis A ^a,b   Chedraui, Peter A ^a,b   Morocho, Nancy ^a,b   Alvarado, Mariela ^a   Chavez, Diana ^a   Huc, Angelica ^a  

^a UNIVERSIDAD CATÓLICA DE SANTIAGO DE GUAYAQUIL   (Ecuador)

^b Foundation for Health and Well Being in the Climacteric FUCLIM   (Ecuador)

Author keywords

Cardiovascular risk; Latin America; Lipid profile; Menopause; Metabolic syndrome

Indexed keywords

TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEMOGRAPHY; DIABETES MELLITUS; ECUADOR; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH EDUCATION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MASS SCREENING; MENOPAUSE; METABOLIC SYNDROME X; OBESITY; PATIENT COUNSELING; POSTMENOPAUSE; PRIORITY JOURNAL; SITTING; WAIST CIRCUMFERENCE;

ADULT; AGED; BODY MASS INDEX; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ECUADOR; FEMALE; HUMANS; HYPERTENSION; LIPIDS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ODDS RATIO; POSTMENOPAUSE; RISK FACTORS;

EID: 33749487604     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590600890272     Document Type: Article

References (29)

1. Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol 1998;148:958-966.
2. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-722.
3. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
4. Groop L, Orho-Melander M. The dysmetabolic syndrome. J Intern Med 2001;250:105-120.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). J Am Med Assoc 2001;285:2486-2497.
6. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. J Am Med Assoc 2002;287:356-359.
7. Zarate A, Basurto L, Hernandez M. [The metabolic syndrome in postmenopausal women. Clinical implications]. Gac Med Mex 2003;139:625-628.
8. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411.
9. Spencer CP, Godsland IF, Stevenson JC. Is there a menopausal metabolic syndrome? Gynecol Endocrinol 1997; 11:341-355.
10. Saglam K, Polat Z, Yilmaz MI, Gulec M, Akinci SB. Effects of postmenopausal hormone replacement therapy on insulin resistance. Endocrine 2002;18:211-214.
11. Sormova I, Donat J. [Risk factors of metabolic estrogendeficiency syndrome in women after menopause and its relationship to hormone replacement therapy]. Ceska Gynekol 2004;69:388-396.
12. Peña M, Bacallao J. Obesity among the poor: an emerging problem in Latin America and the Caribbean. In: Peña M, Bacallao J, editors. Obesity and poverty. A new public health challenge, Scientific Publication No. 576. Washington (DC): Pan American Health Organization; 2000. pp 3-10.
13. Blumel JE, Castelo-Branco C, Roncagliolo ME, Binfa L, Sarra S. [Cardiovascular risk factors in a cohort of middle-aged women]. Rev Med Chil 2003;131:381-389.
14. Sierra B, Hidalgo LA, Chedraui PA. Measuring climacteric symptoms in an Ecuadorian population with the Greene Climacteric Scale. Maturitas 2005;51:236-245.
15. Hidalgo LA, Chedraui PA, Chavez MJ. Obstetrical and neonatal outcome in young adolescents of low socio-economic status: a case control study. Arch Gynecol Obstet 2005;271: 207-211.
16. Castelo-Branco C, Blumel JE, Roncagliolo ME, Haya J, Bolf D, Binfa L, Tacla X, Colondron M. Age, menopause and hormone replacement therapy influences on cardiovascular risk factors in a cohort of middle-aged Chilean women. Maturitas 2003;45:205-212.
17. US Department of Health and Human Services, Public Health Service, National Institutes of Health (NIH). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. NIH Publication No. 98-4080. Bethesda (MD): NIH; 1998.
18. Anderson RN, Kochanek KD, Murphy SL. Report of final mortality statistics, 1995. Natl Vital Stat Rep 1997;45:22-23.
19. National Institutes of Health. Chartbook on cardiovascular, lung and blood diseases. Bethesda (MD): US Department of Health and Human Services; 1992.
20. Body mass index and cardiovascular disease risk factors in seven Asian and five Latin American centers: data from the International Clinical Epidemiology Network (INCLEN). Obes Res 1996;4:221-228.
21. Porrata C, Rodriguez-Ojea, Jimenez S. The epidemiologic transition in Cuba. In: Peña M, Bacallao J, editors. Obesity and poverty. A new public health challenge. Scientific Publication No. 576. Washington (DC): Pan American Health Organization; 2000. pp 51-65.
22. Omran AR. The epidemiologic transition in the Americas. Washington (DC): Pan American Health Organization; 1996.
23. Miller AM, Wilbur J, Chandler PJ, Sorokin O. Cardiovascular disease risk factors and menopausal status in midlife women from the former Soviet Union. Women Health 2003;38: 19-36.
24. The Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principles results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-333.
25. Burlando G, Sanchez RA, Ramos FH, Mogensen CE, Zanchetti A; Latin American Experts Group. Latin American consensus on diabetes mellitus and hypertension. J Hypertens 2004;22:2229-2241.
26. Nadel I, Cypryk K, Pertynski T, Sobczuk A, Stetkiewicz T. [Studies on the incidence and clinical significance of the metabolic syndrome in postmenopausal women in Lodz region]. Pol Arch Med Wewn 2001;106:823-828.
27. Gruppo di Studio Progetto Menopausa Italia. Risk factors for high blood pressure in women attending menopause clinics in Italy. Maturitas 2006;53:83-88.
28. Amigoni S, Morelli P, Parazzini F, Chatenoud L. Determinants of elevated blood pressure in women around menopause: results from a cross-sectional study in Italy. Maturitas 2000;34:25-32.
29. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, Poehlman ET. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001;86:1020-1025.